Comprehensive wellness care may improve overall recovery and support healthier long-term hair growth
Drug Name: Semaglutide Manufacturer: Novo Nordisk Type: GLP-1 agonist Brand Names: Ozempic = Type 2 Diabetes, weekly injection (approved December, 2017) Rebylsus = Type 2 Diabetes, daily pill (approved September, 2019) Wegovy = Weight Loss, weekly injection (approved June, 2021) Drug Name: Tirzepatide Manufacturer: Eli Lilly Type: GLP-1/GIP co-agonist Brand Names: Mounjaro = Type 2 Diabetes, weekly injection (approved May, 2022) Zepbound = Weight Loss Application, weekly injection (approved November, 2023) (No pill form exists as of this writing) The short story is that both drugs were originally introduced as effective Type 2 Diabetes medications
However, outcomes vary widely depending on lifestyle structure, body composition, and medical follow up
For some patients, this adjustment is mild or unnoticed
Our unique multi-action formula incorporates the most powerful ingredients that have been shown to address issues such as tingling, numbness, and burning sensations associated with nerve discomfort